Evidence map›Paper›PMID 26332075›Full record

ArticleJournal of cellular biochemistry2016

Age-Related Changes in FGF-2, Fibroblast Growth Factor Receptors and β-Catenin Expression in Human Mesenchyme-Derived Progenitor Cells.

Marja M Hurley, Gloria Gronowicz, Li Zhu, Liisa T Kuhn, Craig Rodner, Liping Xiao

Abstract read
In one paragraph

Article in Journal of cellular biochemistry, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Consequences of Aging on Bone.Aging and disease · 2023
    Pooled it
  2. Article
  3. Article
  4. Journal of Taibah University Medical Sciences · 2025
    Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Down-Regulation of Fibroblast Growth Factor 2 (FGF2) Contributes to the Premature Senescence of Mouse Embryonic Fibroblast.Medical science monitor : international medical journal of experimental and clinical research · 2020
    Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Marja M HurleyDepartment of Medicine, UCONN Health, Farmington, CT.
Gloria GronowiczDepartment of Surgery, UCONN Health, Farmington, CT.
Li ZhuDepartment of Reconstructive Sciences, UCONN Health, Farmington, CT.
Liisa T KuhnDepartment of Reconstructive Sciences, UCONN Health, Farmington, CT.
Craig RodnerDepartment of Orthopedics, UCONN Health, Farmington, CT.
Liping XiaoDepartment of Medicine, UCONN Health, Farmington, CT.

Funding

Modulated release of growth factors for stimulating progenitors in aging boneR01DE021103 · NIDCR · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI KUHN, LIISA TIINA · 2012 to 2025
$4.4M
NIDCR NIH HHS R01 DE021103NIDCR NIH HHS R01DE021103
6 · The paper itself

Abstract

FGF-2 stimulates preosteoblast replication, and knockout of the FGF-2 gene in mice resulted in osteopenia with age, associated with decreased Wnt-β-Catenin signaling. In addition, targeted expression of FGF-2 in osteoblast progenitors increased bone mass in mice via Wnt-β-Catenin signaling. We posited that diminution of the intrinsic proliferative capacity of human mesenchyme-derived progenitor cells (HMDPCs) with age is due in part to reduction in FGF-2. To test this hypothesis HMDPCs from young (27-38), middle aged (47-56), and old (65-76) female human subjects were isolated from bone discarded after orthopedic procedures. HMDPCs cultures were mostly homogeneous with greater than 90% mesenchymal progenitor cells, determined by fluorescence-activated cell sorting. There was a progressive decrease in FGF-2 and FGFR1 mRNA and protein in HMDPCs with age. Since FGF-2 activates β-catenin, which can enhance bone formation, we also assessed its age-related expression in HMDPCs. An age-related decrease in total-β-Catenin mRNA and protein expression was observed. However there were increased levels of p-β-Catenin and decreased levels of activated-β-Catenin in old HMDSCs. FGF-2 treatment increased FGFR1 and β-Catenin protein, reduced the level of p-β-Catenin and increased activated-β-Catenin in aged HMDPCs. In conclusion, reduction in FGF-2 expression could contribute to age-related impaired function of HMDPCs via modulation of Wnt-β-catenin signaling.

Indexed as

AgingAdultAgedbeta CateninCells, CulturedFemaleFibroblast Growth Factor 2Gene ExpressionHumansMesenchymal Stem CellsMiddle AgedReceptor, Fibroblast Growth Factor, Type 1Wnt Signaling PathwayYoung Adultbeta CateninCTNNB1 protein, humanFGFR1 protein, humanFibroblast Growth Factor 2Receptor, Fibroblast Growth Factor, Type 1AGINGENDOGENOUS FIBROBLAST GROWTH FACTOR-2FIBROBLAST GROWTH FACTOR RECEPTORHUMAN MESENCHYME-DERIVED PROGENITOR CELLSβ-CATENIN

Identifiers

PMID26332075
PMCPMC4861164

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.